Monday, 14 January 2019

Fungus in the Feet: (LOJMS) - Lupine Publishers

Fungus in the Feet byAndrew Hague in LOJ Medical Sciences (LOJMS) - Lupine Publishers


Rich or poor, clean or dirty, infections are always attacking the feet. Here are verrucas which were treated by the local doctor with a freezing spray and ointment and for two years nothing happened until they were zapped with 100 shocks on each verruca, energy level 3 with a 20 mm focal head The verrucas have gone and new skin is taking their place. Note that only one simple treatment was needed. The verrucas are typical of what attacks those who go to swimming pools and gyms. One treatment is all it takes to kill whatever is living in the skin. Tell the patient that all their shoes must be washed or thrown away to avoid re-infection. It makes no sense to clean the feet and then get infected again as soon as they put their shoes back on The same happens with toe nail fungus (Figure 3). The fungus is killed and the nails re-grow. No drugs. No ointments. Quick and easy. It is the ability of CellSonic to kill all and any infection that makes it such an easy to use and safe tool - Lupine Publishers.

For more information click the below link
https://lupinepublishers.com/medical-science-journal/fulltext/fungus-in-the-feet.ID.000113.php
https://lupinepublishers.com/medical-science-journal/abstracts/fungus-in-the-feet.ID.000113.php
https://lupinepublishers.com/medical-science-journal/pdf/LOJMS.MS.ID.000113.pdf

For more Medical Sciences Journals click the below link
https://lupinepublishers.com/medical-science-journal/index.php

For more
Lupine Publishers Journals click the below link
https://lupinepublishers.com/




Tuesday, 8 January 2019

Considerations for Successful Scale-Up To Tox Batches And Phase-Api (Bulk Drugsubstance): LOJMS - Lupine Publishers





Practical Considerations in Pharmaceutical Production Scale-Up- This paper is meant to provide a high-level overview of the steps required to prepare the bulk drug substance API. From first-in-human and through each of the clinical trial stages and into commercialization, scale-up of formulation design is a natural part of pharmaceutical development. At each stage of process development, the batch size increases, from laboratory-scale batches that may be quite small to support preclinical and early clinical stages, to pilot batches that are used in process development, and finally to the production-scale batches needed to support commercialization Lupine publishers.

For more information click on below link


Monday, 24 December 2018

Considerations for Successful Scale-Up To Tox Batches And Phase-Api (Bulk Drugsubstance): LOJMS- Lupine Publishers



Practical Considerations in Pharmaceutical Production Scale-Up- This paper is meant to provide a high-level overview of the steps required to prepare the bulk drug substance API. From first-in-human and through each of the clinical trial stages and into commercialization, scale-up of formulation design is a natural part of pharmaceutical development. At each stage of process development, the batch size increases, from laboratory-scale batches that may be quite small to support preclinical and early clinical stages, to pilot batches that are used in process development, and finally to the production-scale batches needed to support commercialization.


For more Lupine publishers open access journals click the below link
www.lupinepublishers.com

Sunday, 9 December 2018

Cefpodoxime Proxetil and its By-Products: A Comparative Study as Per EP-7: (LOJMS) - Lupine Publishers)




Cephalosporins are the highly used Broad-spectrum antibiotics, belong to β-lactam class. Cephalosporins resemble penicillin in that they have a β-lactam structure, but the five-member thiazolidine ring characteristic of the penicillin is replaced by a sixmember dihydrothiazine ring. The bactericidal action of beta lactam antibiotics is directly attributable to their ability to react with PBP’s. The research work relates to a by-products during process for the industrial manufacture of Cefpodoxime Proxetil. The drug is registered in USP and belongs to 3rd generation drug. It was discovered by Brotzu in fungus Cephalosporium Acremonium which produces a chemical which show antimicrobial activity. Abraham isolated the three fragmentation patterns of cefpodoximeproxetil. Data from this systematic study will help improve the safety and quality of cefpodoxime proxetil types of cephalosporin antibiotics cephalosporin P, cephalosporin N, cephalosporin C.7-ACA is widely used as the substrate for synthesizing cephalosporinantibiotics. Modification of the 7-ACA side-chains resulted in the development of useful antibiotic agents, and the first agent is Cephalothin (cefalotin) was launched by. Eli Lilly Company in 1964 There are many patents which gives the procedure of Synthesis of Cefpodoxime ProxetilStability of three Cefpodoxime proxetil products available in indian market at fridge temperatures (2-8 °C), room temperature (25 °C) and elevated temperature (42 °C). Flow properties, rheological and the physicochemical parameters of both powder and reconstituted powder were used to evaluate the stability of different brands of Cefpodoxime proxetil available in india. The powder of stability samples was eluted through a C18 column with formic acid-methanol-water as the mobile phase. In total, 15 impurities were characterized in commercial samples, including 7 known impurities and 8 new impurities. The structures of these unknown compounds were deduced via comparison in Lupine Publishers.

Monday, 3 December 2018

The Body Electric: Humans Have A ‘Force Field’ Around Their Bodies

  Abstract Bioelectronic medicine (BEM) is the most recent medical revolution — not an innovation or an improvement or a step up but a radic...